Symphony Financial »

Iovance Biotherapeutics shares owned by Symphony Financial

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Symphony Financial from 13F filings

Historical chart of Symphony Financial investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Symphony Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Symphony Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $34k 10k 3.39

More positions owned by Symphony Financial

Spdr Series Trust State Street Spd (SPTM)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYG)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Apple (AAPL)
Amazon (AMZN)
Spdr Gold Tr Gold Shs (GLD)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (SPIB)
Spdr Series Trust State Street Spd (SPYV)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Exxon Mobil Corporation (XOM)
Alphabet Cap Stk Cl A (GOOGL)
American Centy Etf Tr Avantis Emgmkt (AVEM)

View all positions for Symphony Financial

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
Vanguard Group
State Street Corporation
Vanguard Capital Management
Two Sigma Investments
Vanguard Portfolio Management
Millennium Management
Goldman Sachs Group
Geode Capital Management
Invenomic Capital Management
Bank of America Corporation
D. E. Shaw & Co
Susquehanna International
Palo Alto Investors

View all funds holding Iovance Biotherapeutics